Skip to content
healthcare.dev

Topotecan Hydrochloride

NDC 63323-762, TOPOTECAN HYDROCHLORIDE, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-762
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091089
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-762 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPOTECAN HYDROCHLORIDE4 mg/4mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
63323-762-10633230762101 VIAL in 1 BOX (63323-762-10) / 4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b6019088-cd94-43b4-b5ce-ba20b6b8021e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-762

Use it

Look up 63323-762 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-762 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-762. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.